Current Progress in CAR-T Cell Therapy for Solid Tumors

Cancer immunotherapy by chimeric antigen receptor-modified T (CAR-T) cells has shown exhilarative clinical efficacy for hematological malignancies. Recently two CAR-T cell based therapeutics, Kymriah (Tisagenlecleucel) and Yescarta (Axicabtagene ciloleucel) approved by US FDA (US Food and Drug Admin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Biol Sci
Egile Nagusiak: Ma, Shuo, Li, Xinchun, Wang, Xinyue, Cheng, Liang, Li, Zhong, Zhang, Changzheng, Ye, Zhenlong, Qian, Qijun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2019
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6854376/
https://ncbi.nlm.nih.gov/pubmed/31754328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.34213
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak